Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This phase II trial with a safety run-in component will evaluate whether the addition of pembrolizumab to Stereotactic Body Radiation Therapy (SBRT) re-irradiation will improve the progression-free survival for patients with recurrent or new second primary Head and Neck Squamous Cell Carcinoma (HNSCC).
Sponsor: RTOG Foundation, Inc.
Check if you qualify for this head and neck cancer clinical trial in St Louis, MO
If you're searching for head and neck cancer treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.